Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... are under NF-kappa B transcriptional control, was inhibited and mRNA expression for cyclooxygenase-2, an NF-kappa B target gene, was reduced. CRLPs enriched in polyunsaturated fatty acids ...
2009 NOV 23 ... a Phase II trial to investigate the efficacy of combined therapy with meloxicam, a cyclooxygenase-2 inhibitor and natural interferon (IFN)-alpha in renal cell carcinoma patients with ...
2009 NOV 24 ... induces and maintains prostaglandin endoperoxide synthase 2 (PTGS2, also known as cyclooxygenase 2) expression in vas deferens epithelial cells, but it remains unknown whether this has ...
2009 NOV 23 ... "Wang ZY, Wang P, Bjorling DE. Role of mast cells and proteaseactivated receptor-2 in cyclooxygenase-2 expression in urothelial cells," researchers in the United States report. ...
2009 NOV 23 ... adrenal glands. V1aR was found to specifically co-express at the macula densa cells with cyclooxygenase (COX)-2 and with neuronal nitric oxide synthase, which produces potent stimulators of ...
2009 NOV 23 ... Design, Synthesis, and in Vitro and in Vivo Pharmacological Evaluation as Promising Cyclooxygenase 1 and 2 Inhibitors. Journal of Medicinal Chemistry, 2009;52(19):5864-5871). ...
2009 NOV 23 ... MMP-9, and MMP-13 as well as in levels of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) in the skin. Based on histological evaluation, they prevented increases in the ...
2009 NOV 23 ... The expression of tumour necrosis factor alpha, IL-1b, IL-6, matrix metalloproteinase 3, cyclooxygenase 2 and inducible nitric oxide synthase decreased in bortezomib-treated mice compared with ...
2009 NOV 23 ... According to recent research from Lebanon, "Cyclooxygenase-2 (COX-2) catalyzes the rate-limiting step in the production of prostaglandins, potent ...
2009 NOV 23 ... signet ring cells, CIMP, MSI, LINE-1 hypomethylation, BRAF, p53, p21, beta-catenin, or cyclooxygenase-2. VDR expression was not significantly related with patient survival, prognosis, or ...
2009 NOV 27 ... This can be explained by the significant production of prostaglandin E-2, activating cyclooxygenase-dependent mechanisms in epithelia and thus inhibiting lung inflammation. The ...
2009 NOV 23 ... cell adhesion molecule-1, intercellular adhesion molecule-1, endothelial selectin, and cyclooxygenase-2 protein expression as well as monocyte chemotactic protein-1, tissue factor, and ...
2009 NOV 23 ... eosinophils and basophils in the protease group coinciding with lower levels of serum cyclooxygenase 2, interleukin 6, and interleukin 12 in this group," wrote T.W. Buford and colleagues, ...
2009 NOV 23 ... scavenging activity (O2(center dot-), OH-, H2O2). The ability of the extracts to inhibit cyclooxygenase enzymes (COX-1 and COX-2) was determined by calculating percent inhibition of PGE(2) ...
2009 NOV 23 ... treatment of women suffering from heavy menstrual bleeding. Keywords: Cyclooxygenase Inhibitor, Diclofenac, FDA, Gynecology, Menstruation, NSAID, Pain Management, ...
